Latest Chronic leukemia Stories

2012-05-31 01:19:22

-SMIP-016 is a promising experimental drug that kills chronic leukemia cells. -The drug targets a protein called CD37, but it wasn´t known how this kills leukemia cells. -This study showed unexpectedly that CD37 helps regulate both cell-death and cell-survival signals, explaining how the drug works and how it might be improved. A new study has identified a life-and-death signaling role for a molecule on the surface of the immune cells involved in the most common form of chronic...

2011-08-17 15:09:06

New drug, in early clinical testing, offers some clues While testing a new drug designed to treat chronic leukemia, researchers at Cleveland Clinic discovered new markers that could identify which patients would receive maximum benefit from the treatment. This information was released in the online edition of Blood, a weekly medical journal published by the American Society of Hematology. Chronic lymphocytic leukemia (CLL), a cancer of the white blood cells that is incurable with standard...

2010-03-05 09:12:32

Researchers have discovered a key reason why a form of leukemia progresses from its more-treatable chronic phase to a life-threatening phase called blast crisis. The study, led by cancer researchers at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), indicates that chronic myeloid leukemia (CML) progresses when immature white blood cells lose a molecule called miR-328. Loss of the molecule traps the...

2008-12-05 12:39:10

In 1958, Ohio State University cancer researcher Dr. Bertha Bouroncle first identified a deadly disease now known as hairy-cell leukemia, a once fatal disease that can now be effectively treated.Now, 50 years later researchers from across the globe are gathering for a symposium titled "50 years of Enormous Progress in Hairy Cell Leukemia: A Celebration of Clinical Research with Remaining Unanswered Questions."The free Friday Satellite Symposium, which precedes the 50th American Society of...

2007-06-22 15:10:42

WHITE PLAINS, N.Y., Jun. 22 /PRNewswire-USNewswire/ -- Neil Shah, M.D., PHD, an expert on leukemia, will discuss novel treatment approaches for chronic myelogenous leukemia (CML) in a free telephone workshop entitled The Latest on CML - Update from the American Society of Clinical Oncology (ASCO) Annual Meeting. The program is scheduled for Thursday, Jun. 28, 2007, 12:00 p.m. - 1:30 p.m. ET. Dr. Shah, assistant professor for the division of Hematology/Oncology Department of Medicine at the...

Word of the Day
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.